Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin vs Placebo for GAS Pharyngitis in Children (GASPARD)
NCT03264911Phase 4Unknown
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in group A streptococcal pharyngitis (GAS) comparing Amoxicillin Arm with Placebo Arm (2 arms). Primary endpoint: Non-inferiority at 1 month. Status: unknown.
02
Drugs
amoxicillin
03
Conditions
group A streptococcal pharyngitis (GAS)
Beyond the preview
Go deeper on NCT03264911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264911.